SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (258)10/15/1998 11:29:00 AM
From: Richard Haugland  Read Replies (1) | Respond to of 3044
 
Abgenix and Millennium BioTherapeutics Form Collaboration

Collaboration Marks Sixth Corporate Deal for Abgenix and Start of Development For Millennium BioTherapeutic's Second Clinical Candidate

biz.yahoo.com



To: scaram(o)uche who wrote (258)10/21/1998 2:38:00 PM
From: scaram(o)uche  Respond to of 3044
 
exchange2000.com

The name of the game is *still* gene -----> product.

Everything negative from the last year is analyst and
fund manager B.S.

Nobody is going to put more screens under the nose of
chemical panels than MLNM.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News